staurosporine has been researched along with Myocardial Infarction in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boivin, MN; Bouchentouf, M; Boulassel, MR; Cuerquis, J; Forner, KA; Galipeau, J; Paradis, P; Routy, JP; Schiffrin, EL; Zheng, J | 1 |
| Dettwiler, S; Kratz, M; Müllenheim, J; Obal, D; Preckel, B; Schlack, W; Toma, O; Weber, NC; Wolter, JI; Zacharowski, K | 1 |
| Baba, K; Fujiwara, H; Kariya, T; Kawai, T; Minatoguchi, S; Takahashi, M; Takemura, G; Uno, Y; Zhang, C | 1 |
| Fauconnier, J; Lacampagne, A; Rauzier, JM; Richard, S; Vassort, G | 1 |
| Goto, M; Iimura, O; Miura, T; Sakamoto, J | 1 |
| Heusch, G; Onallah, R; Post, H; Schulz, R; Vahlhaus, C | 1 |
| Cohen, MV; Downey, JM; Sato, H; Yang, XM | 1 |
| Heusch, G; Post, H; Rose, J; Schulz, R; Vahlhaus, C | 1 |
| Goto, M; Kawamura, S; Matsuzaki, M; Miura, T; Sakamoto, J; Shimamoto, K; Tsuchida, A | 1 |
| Latchman, DS; Marber, MS; Miller, AD; Renner, O; Stewart, L; Sugden, PH; Wightman, L; Zhao, J | 1 |
| Olbrich, A; Thiemermann, C; Zacharowski, K | 1 |
| Hasegawa, T; Matsumoto, T; Miura, T; Nozawa, Y; Shimamoto, K; Tanno, M; Tsuchida, A | 1 |
| Braun-Dullaeus, R; Marquetant, R; Strasser, RH; Walendzik, H | 1 |
13 other study(ies) available for staurosporine and Myocardial Infarction
| Article | Year |
|---|---|
Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction.
Topics: Animals; Apoptosis; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Endothelial Cells; Female; Flow Cytometry; Hepatocyte Growth Factor; Humans; Insulin-Like Growth Factor I; Mice; Mice, Inbred C57BL; Monocytes; Muscle Cells; Myocardial Infarction; Neovascularization, Physiologic; Receptors, Tumor Necrosis Factor, Type I; Staurosporine; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2010 |
Role of protein kinase C-epsilon (PKCepsilon) in isoflurane-induced cardioprotection.
Topics: Anesthetics, Inhalation; Animals; Cardiotonic Agents; Cell Membrane; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Hemodynamics; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Rats; Rats, Wistar; Staurosporine | 2005 |
Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Protein Kinase C; Quinazolines; Rabbits; Receptor, Adenosine A1; Receptors, Adrenergic, alpha-1; Staurosporine; Theophylline; Tyramine; Vasodilator Agents | 2005 |
Ca2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure?
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Depression, Chemical; Egtazic Acid; Heart Failure; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardium; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Protein Kinase C; Rats; Rats, Wistar; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sirolimus; Staurosporine; Tacrolimus | 2005 |
Limitation of myocardial infarct size by adenosine A1 receptor activation is abolished by protein kinase C inhibitors in the rabbit.
Topics: Alkaloids; Animals; Dose-Response Relationship, Drug; Male; Myocardial Infarction; Myocardium; Phenylisopropyladenosine; Polymyxin B; Protein Kinase C; Rabbits; Staurosporine; Stimulation, Chemical; Tetradecanoylphorbol Acetate | 1995 |
No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine.
Topics: Alkaloids; Animals; Coronary Circulation; Enzyme Inhibitors; Heart; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Protein Kinase C; Staurosporine; Swine; Swine, Miniature | 1996 |
Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation.
Topics: Animals; Enzyme Activation; Enzyme Inhibitors; Female; Heart; Hemodynamics; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; Protein Kinase C; Rabbits; Staurosporine | 1997 |
Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs.
Topics: Animals; Coronary Circulation; Enzyme Activation; Enzyme Inhibitors; Female; Genistein; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Protein Kinase C; Protein-Tyrosine Kinases; Rabbits; Signal Transduction; Staurosporine; Swine; Swine, Miniature | 1998 |
Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
Topics: Animals; Cell Membrane; Cytosol; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; Polymyxin B; Protein Kinase C; Purinergic P1 Receptor Antagonists; Rabbits; Random Allocation; Staurosporine; Theophylline | 1998 |
The expression of constitutively active isotypes of protein kinase C to investigate preconditioning.
Topics: Animals; Animals, Newborn; beta-Galactosidase; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Genes, Reporter; Ischemic Preconditioning, Myocardial; Isoenzymes; Myocardial Infarction; Myocardial Ischemia; Myocardium; Protein Kinase C; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Staurosporine; Time Factors; Transfection | 1998 |
Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels.
Topics: Adenosine Triphosphate; Alkaloids; Animals; Anti-Arrhythmia Agents; Benzophenanthridines; Decanoic Acids; Enzyme Inhibitors; Epoprostenol; Hemodynamics; Hydroxy Acids; Male; Myocardial Infarction; Myocardial Reperfusion; Phenanthridines; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Staurosporine | 1999 |
Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.
Topics: Analysis of Variance; Animals; Blood Pressure; Enzyme Inhibitors; Genistein; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Potassium Channels; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Staurosporine | 2000 |
Alpha 1-receptor-independent activation of protein kinase C in acute myocardial ischemia. Mechanisms for sensitization of the adenylyl cyclase system.
Topics: Adenylyl Cyclases; Alkaloids; Animals; Enzyme Activation; In Vitro Techniques; Myocardial Infarction; Perfusion; Polymyxin B; Protein Kinase C; Rats; Receptors, Adrenergic, alpha; Reperfusion; Staurosporine; Time Factors | 1992 |